Mr. Stephen Mulvany:

I apologise; I was coming to Deputy O'Connell's question. In some of the approvals that are granted, access is restricted to a certain protocol-driven access. In some cases, we place a cap on the level of resources depending on the subsequent efficacy results. Whether we can ever cease reimbursing an individual patient is beyond my level of knowledge so I will not comment on it. I will get the Deputy an answer to the question.